Tuesday, March 18, 2025 | 06:38 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AstraZeneca Pharma India and Mankind Pharma ink distribution agreement

Image

To improve access to Symbicort (asthma drug) in India

AstraZeneca Pharma India and Mankind Pharma entered into an agreement for exclusive distribution of AstraZeneca's budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India. AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be the Marketing Authorisation Holder (MAH) and import license.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 11 2024 | 3:39 PM IST

Explore News